Members Can Post Anonymously On This Site
Burning meteor plunges to the ground in Jinhua, China
-
Similar Topics
-
By NASA
Teams with NASA are gaining momentum as work progresses toward future lunar missions for the benefit of humanity as numerous flight hardware shipments from across the world arrived at the agency’s Kennedy Space Center in Florida for the first crewed Artemis flight test and follow-on lunar missions. The skyline at Kennedy will soon see added structures as teams build up the ground systems needed to support them.
Crews are well underway with parallel preparations for the Artemis II flight, as well as buildup of NASA’s mobile launcher 2 tower for use during the launch of the SLS (Space Launch System) Block 1B rocket, beginning with the Artemis IV mission. This version of NASA’s rocket will use a more powerful upper stage to launch with crew and more cargo on lunar missions. Technicians have begun upper stage umbilical connections testing that will help supply fuel and other commodities to the rocket while at the launch pad.
In summer 2024, technicians from NASA and contractor Bechtel National, Inc. completed a milestone called jack and set, where the center’s mega-mover, the crawler transporter, repositioned the initial steel base assembly for mobile launcher 2 from temporary construction shoring to its six permanent pedestals near the Kennedy’s Vehicle Assembly Building.
Teams at Bechtel National, Inc. use a crane to lift Module 4 into place atop the mobile launcher 2 tower chair at its park site on Jan. 3, 2025, at Kennedy Space Center in Florida. Module 4 is the first of seven modules that will be stacked vertically to make up the almost 400-foot launch tower that will be used beginning with the Artemis IV mission.Betchel National Inc./Allison Sijgers “The NASA Bechtel mobile launcher 2 team is ahead of schedule and gaining momentum by the day,” stated Darrell Foster, ground systems integration manager, NASA’s Exploration Ground Systems Program at NASA Kennedy. “In parallel to all of the progress at our main build site, the remaining tower modules are assembled and outfitted at a second construction site on center.”
As construction of the mobile launcher 2’s base continues, the assembly operations shift into integration of the modules that will make up the tower. In mid-October 2024, crews completed installation of the chair, named for its resemblance to a giant seat. The chair serves as the interface between the base deck and the vertical modules which are the components that will make up the tower, and stands at 80-feet-tall.
In December 2024, teams completed the rig and set Module 4 operation where the first of a total of seven 40-foot-tall modules was stacked on top of the chair. Becthel crews rigged the module to a heavy lift crane, raised the module more than 150-feet, and secured the four corners to the tower chair. Once complete, the entire mobile launcher structure will reach a height of nearly 400 feet – approximately the length of four Olympic-sized swimming pools placed end-to-end.
On the opposite side of the center, test teams at the Launch Equipment Test Facility are testing the new umbilical interfaces, which will be located on mobile launcher 2, that will be needed to support the new SLS Block 1B Exploration Upper Stage. The umbilicals are connecting lines that provide fuel, oxidizer, pneumatic pressure, instrumentation, and electrical connections from the mobile launcher to the upper stage and other elements of SLS and NASA’s Orion spacecraft.
“All ambient temperature testing has been successfully completed and the team is now beginning cryogenic testing, where liquid nitrogen and liquid hydrogen will flow through the umbilicals to verify acceptable performance,” stated Kevin Jumper, lab manager, NASA Launch Equipment Test Facility at Kennedy. “The Exploration Upper Stage umbilical team has made significant progress on check-out and verification testing of the mobile launcher 2 umbilicals.”
https://www.nasa.gov/wp-content/uploads/2025/01/eusu-test-3-5b-run-1.mp4 Exploration Upper Stage Umbilical retract testing is underway at the Launch Equipment Test Facility at Kennedy Space Center in Florida on Oct. 22, 2024. The new umbilical interface will be used beginning with the Artemis IV mission. Credit: LASSO Contract LETF Video Group The testing includes extension and retraction of the Exploration Upper Stage umbilical arms that will be installed on mobile launcher 2. The test team remotely triggers the umbilical arms to retract, ensuring the ground and flight umbilical plates separate as expected, simulating the operation that will be performed at lift off.
View the full article
-
By European Space Agency
The European Space Agency’s Milky Way-mapper Gaia has completed the sky-scanning phase of its mission, racking up more than three trillion observations of about two billion stars and other objects over the last decade to revolutionise the view of our home galaxy and cosmic neighbourhood.
View the full article
-
By Amazing Space
Winter Sky Guide: Orion, Pleiades & Jupiter Alignment | Meteor Shower Captured! Stargazing
-
By NASA
6 min read
Preparations for Next Moonwalk Simulations Underway (and Underwater)
In-person participants L-R standing: Dave Francisco, Joanne Kaouk, Dr. Richard Moon, Dr. Tony Alleman, Dr. Sean Hardy, Sarah Childress, Kristin Coffey, Dr. Ed Powers, Dr. Doug Ebersole, Dr. Steven Laurie, Dr. Doug Ebert; L-R seated: Dr. Alejandro Garbino, Dr. Robert Sanders, Dr. Kristi Ray, Dr. Mike Gernhardt, Dr. Joseph Dervay, Dr. Matt Makowski). Not pictured: Dr. Caroline Fife In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground testing and human subject studies.
Decompression sickness (DCS) is a condition which results from dissolved gases (primarily nitrogen) forming bubbles in the bloodstream and tissues. It is usually experienced in conditions where there are rapid decreases in ambient pressure, such as in scuba divers, high-altitude aviation, or other pressurized environments. The evolved gas bubbles have various physiological effects and can obstruct the blood vessels, trigger inflammation, and damage tissue, resulting in symptoms of DCS. NASA presently classifies DCS into two categories: Type I DCS, which is less severe, typically leads to musculoskeletal symptoms including pain in the joints or muscles, or skin rash. Type II DCS is more severe and commonly results in neurological, inner ear, and cardiopulmonary symptoms. The risk of DCS in spaceflight presents during extravehicular activities (EVAs) in which astronauts perform mission tasks outside the spaceflight vehicle while wearing a pressurized suit at a lower pressure than the cabin pressure. DCS mitigation protocols based on strategies to reduce systemic nitrogen load are implemented through the combination of habitat environmental parameters, EVA suit pressure, and breathing gas procedures (prebreathe protocols) to achieve safe and effective mission operations. The pathophysiology of DCS has still not been fully elucidated since cases occur despite the absence of detected gas bubbles but includes right to left shunting of venous gas emboli (VGE) via several potential mechanisms, one of which is a Patent Foramen Ovale (PFO).
From: Dr. Schochet & Dr. Lie, Pediatric Pulmonologists
Reference OCHMO-TB-037 Decompression Sickness (DCS) Risk Mitigation technical brief for additional information.
A PFO is a shunt between the right atrium and the left atrium of the heart, which is a persisting remnant of a physiological communication present in the fetal heart. Post-natal increases in left atrial pressure usually force the inter-septal valve against the septum secundum and within the first 2 years of life, the septae permanently fuse due to the development of fibrous adhesions. Thus, all humans are born with a PFO and approximately 75% of PFOs fuse following childbirth. For the 25% of the population’s whose PFOs do not fuse, ~6% have what is considered by some to be a large PFO (> 2 mm). PFO diameter can increase with age. The concern with PFOs is that with a right to left shunt between the atria, venous emboli gas may pass from the right atrium (venous) to the left atrium (arterial) (“shunt”), thus by-passing the normal lung filtration of venous emboli which prevent passage to the arterial system. Without filtration, bubbles in the arterial system may lead to a neurological event such as a stroke. Any activity that increases the right atrium/venous pressure over the left atrium/arterial pressure (such as a Valsalva maneuver, abdominal compression) may further enable blood and/or emboli across a PFO/shunt.
From: Nuffield Department of Clinical Neurosciences
The purpose of this working group was to review and provide analysis on the status and progress of research and clinical activities intended to mitigate the risk of PFO and DCS issues during spaceflight. Identified cases of DCS during NASA exploration atmosphere ground testing conducted in pressurized chambers led to the prioritization of the given topic for external review. The main goals of the working group included:
Quantification of any increased risk associated with the presence of a PFO during decompression protocols utilized in ground testing and spaceflight EVAs, as well as unplanned decompressions (e.g., cabin depressurization, EVA suit leak). Describe risks and benefits of PFO screening in astronaut candidates, current crewmembers, and chamber test subjects. What are potential risk reduction measures that could be considered if a person was believed to be at increased risk of DCS due to a PFO? What research and/or technology development is recommended that could help inform and/or mitigate PFO-related DCS risk? The working group took place over two days at NASA’s Johnson Space Center and included NASA subject matter experts and stakeholders, as well as invited external reviewers from areas including cardiology, hypobaric medicine, spaceflight medicine, and military occupational health. During the working group, participants were asked to review past reports and evidence related to PFOs and risk of DCS, materials and information regarding NASA’s current experience and practices, and case studies and subsequent decision-making processes. The working group culminated in an open-forum discussion where recommendations for current and future practices were conferred and subsequently summarized in a final summary report, available on the public NASA OCHMO Standards Team website.
The following key findings are the main take-aways from the OCHMO independent assessment:
In an extreme exposure/high-risk scenario, excluding individuals with a PFO and treating PFOs does not necessarily decrease the risk of DCS or create a ‘safe’ environment. It may create incremental differences and slightly reduce overall risk but does not make the risk zero. There are other physiological factors that also contribute to the risk of DCS that may have a larger impact (see 7.0 Other Physiological Factors in the findings section). Based on the available evidence and the risk of current decompression exposures (based on current NASA protocols and NASA-STD-3001 requirements to limit the risk of DCS), it is not recommended to screen for PFOs in any spaceflight or ground testing participants. The best strategy to reduce the risk of DCS is to create as safe an environment as possible in every scenario, through effective prebreathe protocols, safety, and the capability to rapidly treat DCS should symptoms occur. Based on opinion, no specific research is required at this time to further characterize PFOs with DCS and altitude exposure, due to the low risk and preference to institute adequate safe protocols and ensuring treatment availability both on the ground and in spaceflight. For engineering protocols conducted on the ground, it should be ensured that the same level of treatment capability (treatment chamber in the immediate vicinity of the testing) is provided as during research protocols. The ability to immediately treat a DCS case is critical in ensuring the safety of the test subjects. The full summary report includes detailed background information, discussion points from the working group, and conclusions and recommendations. The findings from the working group and resulting summary report will help to inform key stakeholders in decision-making processes for future ground testing and spaceflight operations with the main goal of protecting crew health and safety to ensure overall mission success.
Summary Report About the Author
Sarah D. Childress
Share
Details
Last Updated Dec 31, 2024 Related Terms
Office of the Chief Health and Medical Officer (OCHMO) Human Health and Performance Humans in Space International Space Station (ISS) Explore More
2 min read Station Science Top News: Dec. 20, 2024
Article 2 weeks ago 4 min read Artemis II Core Stage Vertical Integration Begins at NASA Kennedy
Article 2 weeks ago 3 min read NASA, Axiom Space Change Assembly Order of Commercial Space Station
Article 2 weeks ago Keep Exploring Discover More Topics From NASA
Missions
Humans in Space
Climate Change
Solar System
View the full article
-
By USH
A rare and intriguing phenomenon has been observed in China. On the night of October 27th, Chinese astrophotographer Shengyu Li set up his camera to capture star trails over Mount Xiannairi in Sichuan Province. To his surprise, he recorded mysterious blue flashes accompanying an avalanche.
The exact cause of these "blue lights" remains unclear, sparking various theories. Some speculate they could stem from geomagnetic activity, interactions of cosmic rays in the upper atmosphere, or rare atmospheric phenomena like blue jets or elves. However, Li offers another explanation: the flashes might result from triboluminescence—light produced by friction during ice fragmentation.
Triboluminescence occurs when certain materials emit light as they are fractured, scratched, or rubbed. This phenomenon happens due to the breaking of chemical bonds or the sudden separation of surfaces, which generates electrical charges. These charges can ionize the surrounding air or excite the material itself, creating visible light.
The hypothesis suggests that this event could be an example of triboluminescence. However, it also raises the intriguing possibility of a connection to UFO phenomena, such as orbs or other unexplained lights that have been observed around the world over the years.
Hypothesis: The sighting depicts what appears to be a blue light descending onto a snowbank, following the avalanche as it moves downward, and then vanishing before seemingly ascending again.
Did the avalanche trigger the blue light, or did the blue light crash into the snow, causing the avalanche?
Whether this phenomenon is a rare case of triboluminescence, potentially the first instance of it being captured on camera or something linked to unexplained UFO activity, the recording of this light remains a unique and fascinating occurrence. View the full article
-
-
Check out these Videos
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.